PCN16 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT TRASTUZUMAB FOR HER-2 POSITIVE EARLY BREAST CANCER IN TAIWAN
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65174-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)65174-1/fulltext
Section Title :
Section Order :
333
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65174-1&doi=10.1016/S1098-3015(10)65174-1